Drug Discovery News and Research

RSS

The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.

VOYAGER electronic pipettes support breakthroughs in analgesia research

Purdue University researchers use VOYAGER pipettes to enhance drug discovery for non-opioid chronic pain therapies, improving assay throughput and accuracy.

From INTEGRA Biosciences 9 Jul 2026

New EV-SELEX strategy accelerates drug discovery for wide range of GPCRs

G protein-coupled receptors (GPCRs) are the most abundantly expressed proteins in the human body, which regulate diverse physiological processes ranging from pain perception to hormone signaling.

7 Jul 2026

Insilico Medicine highlights AI drug discovery progress at executive summit

Dr. Alex Aliper, Co-founder and President of Insilico Medicine, will attend the AI for Good Global Summit 2026 in Geneva, Switzerland, on July 7.

3 Jul 2026

New genome editing tool unlocks fungi's hidden drug-producing potential

Researchers have spent decades-and billions of dollars-sequencing animal and crop genomes, but fungi have historically been the forgotten middle child of genomics, only noticed when they're ruining bread or colonizing toes.

2 Jul 2026

New grants advance AI-powered wastewater pathogen surveillance

Detecting infectious disease threats early and responding quickly can dramatically alter the course of an infectious outbreak.

2 Jul 2026

Insilico Medicine partners with Takeda for AI-driven drug discovery

Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, today announced a strategic collaboration agreement with Takeda to use its proprietary end-to-end platform, Pharma.AI, to advance drug candidates across the company's therapeutic areas.

2 Jul 2026

USC scientists target brain inflammation to prevent Alzheimer's disease

An interdisciplinary team at the USC Center for Personalized Brain Health (CPBH) is targeting a family of enzymes that can increase the risk of inflammation in the brains of people with the APOE4 gene variation-the most significant genetic risk factor for late-onset Alzheimer's-as a way to prevent the disease.

2 Jul 2026

Duke engineers grow retinal blood vessel cells from pluripotent stem cells

Biomedical engineers at Duke University have used induced pluripotent stem cells (iPSCs) to grow specialized blood vessel cells critical to retinal health for the first time.

30 Jun 2026

Japanese study links inherited genetic variants to multiple lung cancers

Lung cancer remains the leading cause of cancer-related deaths worldwide and is generally thought to arise from mutations acquired over a lifetime through environmental exposures.

30 Jun 2026

Pharmacy expert calls for hybrid digital-human models in NHS healthcare

A pharmacy academic from Kingston University has provided special expertise to the UK Parliament on two key Health and Social Care Committee inquiries.

30 Jun 2026

Scientists capture atomic images to improve RNA interference drug design

RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.

29 Jun 2026

Scaling organoid workflows with automation and AI for drug discovery

Discover how automation, AI, and organoid technologies are improving drug discovery through scalable workflows.

From Molecular Devices UK Ltd 29 Jun 2026

Advancing 3D imaging, automation, and phenotypic discovery with AI-driven high-content screening

Discover how AI-driven high-content screening improves 3D imaging, segmentation, and automation.

From Molecular Devices UK Ltd 29 Jun 2026

Scientists discover 70 existing drugs that block deadly hantavirus infections

Researchers screened over 5,000 compounds and successfully pinpointed 70 existing drugs, including unexpected beta-lactam antibiotics, that effectively suppress Puumala orthohantavirus infection in human cells. This milestone drug-repurposing study provides an immediate, fast-tracked pipeline for developing the first approved treatments against life-threatening hantavirus diseases.

28 Jun 2026

NVIDIA announces BioNeMo Agent Toolkit — Tools for agents to accelerate scientific discovery

NVIDIA today announced NVIDIA BioNeMo Agent Toolkit, which provides domain-specific tools and skills for the agentic life sciences era.

From Benchling 25 Jun 2026

Researchers uncover key mechanism driving chronic Sjögren disease

Sjögren disease, an autoimmune disease characterized by dry mouth and dry eyes, may reduce patients’ quality of life.

24 Jun 2026

New project aims to systematically map billion cellular interactions

...

23 Jun 2026

Insilico and SK Biopharmaceuticals partner to develop AI-driven neuroimmune therapies

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and SK Biopharmaceuticals, a Korean-based company leads the way in biotech innovation with groundbreaking drug research, development, and commercialization worldwide, announced a research and development collaboration at the BIO 2026 International Convention to discover AI-enabled innovative drug candidates in the neuroimmune area of the central nervous system.

22 Jun 2026

Natural molecule erucamide helps slow progressive retinal degeneration

Many conditions that cause vision loss share a common feature: the gradual breakdown of the retina, the light-sensing tissue at the back of the eye.

22 Jun 2026

New chemistry database helps speed up global drug discovery

Developing new medicines can require thousands of chemistry experiments to identify the right recipe for a safe, effective and ideally affordable drug.

22 Jun 2026